Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity ; volume:11 ; number:1 ; day:15 ; month:11 ; year:2012 ; pages:1-8 ; date:12.2012
Cardiovascular diabetology ; 11, Heft 1 (15.11.2012), 1-8, 12.2012
- Creator
-
Li, Chun-jun
Li, Jing
Zhang, Qiu-mei
Lv, Lin
Chen, Rui
Lv, Chun-feng
Yu, Pei
Yu, De-min
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1475-2840-11-142
- URN
-
urn:nbn:de:101:1-2021082420142979878282
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Li, Chun-jun
- Li, Jing
- Zhang, Qiu-mei
- Lv, Lin
- Chen, Rui
- Lv, Chun-feng
- Yu, Pei
- Yu, De-min
- SpringerLink (Online service)
Other Objects (12)
Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report
Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case series
Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin
Galenics of insulin : the physico-chem. and pharmaceut. aspects of insulin and insulin preparations
Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B
Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study
The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report
Hypoglycaemia and human insulin
Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes
Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study
TCF7L2 correlation in both insulin secretion and postprandial insulin sensitivity
Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report
Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case series
Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin
Galenics of insulin : the physico-chem. and pharmaceut. aspects of insulin and insulin preparations
Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B
Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study
The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report
Hypoglycaemia and human insulin
Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes
Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study
TCF7L2 correlation in both insulin secretion and postprandial insulin sensitivity
Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report
Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case series
Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin
Galenics of insulin : the physico-chem. and pharmaceut. aspects of insulin and insulin preparations
Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B
Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study
The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report
Hypoglycaemia and human insulin
Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes
Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study